Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetGTPase KRas
LigandBDBM50579992
Substrate/Competitorn/a
Meas. Tech.ChEMBL_2146126 (CHEMBL5030406)
IC50 9.00±n/a nM
Citation Rosse, G A Series of Pyrazole Analogs Binding to KRASG12C as Potential Cancer Treatment. ACS Med Chem Lett13:11-12 (2022) [PubMed]  Article
More Info.:Get all data from this article,  Assay Method
 
GTPase KRas
Name:GTPase KRas
Synonyms:GTPase KRas, N-terminally processed | K-Ras 2 | KRAS | KRAS2 | Ki-Ras | RASK2 | RASK_HUMAN | c-K-ras | c-Ki-ras
Type:PROTEIN
Mol. Mass.:21656.10
Organism:Homo sapiens (Human)
Description:ChEMBL_1476955
Residue:189
Sequence:
MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAG
QEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDL
PSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGC
VKIKKCIIM
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM50579992
n/a
NameBDBM50579992
Synonyms:CHEMBL5080264 | US11702409, Example 69b
TypeSmall organic molecule
Emp. Form.C31H33ClN8O2
Mol. Mass.585.099
SMILESCOCCn1cc2cc(ccc2n1)-c1nn(C2CC3(C2)CN(C3)C(=O)C=C)c(C)c1-c1c(Cl)c(C)cc2[nH]nc(N)c12 |(88.07,-36.3,;87.02,-35.17,;87.48,-33.7,;86.43,-32.57,;84.93,-32.91,;83.77,-31.89,;82.45,-32.68,;80.99,-32.22,;79.85,-33.25,;80.17,-34.76,;81.64,-35.23,;82.79,-34.19,;84.32,-34.33,;78.39,-32.78,;77.91,-31.32,;76.37,-31.32,;75.47,-30.08,;75.7,-28.56,;74.18,-28.32,;73.95,-29.84,;74.58,-26.83,;73.08,-26.43,;72.69,-27.92,;72.31,-25.1,;73.08,-23.76,;70.77,-25.1,;70,-23.77,;75.9,-32.79,;74.43,-33.27,;77.14,-33.69,;77.16,-35.23,;75.83,-36,;74.5,-35.23,;75.83,-37.54,;74.5,-38.31,;77.16,-38.32,;78.5,-37.54,;79.96,-38.01,;80.87,-36.76,;79.96,-35.52,;79.56,-34.03,;78.5,-35.99,)|
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: